Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165411 · ClinicalTrials.gov registry record
Developing and Maintaining a Central Venous Catheter Registry
A clinical trial, sponsored by Lehigh Valley Hospital.
- Completed
- Registry status
- 4,530
- Enrollment target
NCT01165411: Completed study, sponsored by Lehigh Valley Hospital.
NCT01165411 is a clinical trial that has completed, run by Lehigh Valley Hospital. The registered enrollment target is 4,530 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01165411 has completed, sponsored by Lehigh Valley Hospital.
- COMPLETED
- Registry status
- 4,530 participants
- Enrollment target
Study Summary
It has been estimated that 90% of bloodstream infections associated with catheters, are due to CVCs, and that 500 to 4,000 patients in the United States die annually due to these bloodstream infections. The risk of central line associated bloodstream infections is typically expressed as the number of line infections per 1000 catheter days. This study's goal is to develop a uniform CL protocol, updated practice guidelines based on current evidence, and a standard procedural checklist based on CL care bundles recommended by the Institute for Healthcare Improvement. A secondary goal is to create a CL registry to capture and store data relevant to each CL placed throughout the institution. This registry will provide a wealth of data on CL insertions and complications that may be used as a valuable source of information for quality assurance, performance improvement, and research. With the knowledge and information obtained through this registry, educational offerings can be created, and a standardized institutional process for CL insertion can be developed.
Primary Outcome
All data elements collected are either part of the standard of care during routine insertion of Central Venous Catheters (CVCs) and Peripheral Inserted Central Catheter (PICCs) or are undergoing process improvement so that they become the standard of care for these lines. The hospital data warehouse will be automatically fed information from multiple existing databases that are maintained within different locations of the hospital. Once merged, data will be transferred into the Horizon Business
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,530 participants |
| Start Date | 2008-08 |
| Est. Completion | 2016-01 |
What the finished NCT01165411 record still lists
NCT01165411 is an observational study that tracks outcomes without assigning an intervention. Its 4,530 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01165411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01165411 about?
NCT01165411 is a clinical study titled "Developing and Maintaining a Central Venous Catheter Registry". It has been estimated that 90% of bloodstream infections associated with catheters, are due to CVCs, and that 500 to 4,000 patients in the United States die annually due to these bloodstream infections. The risk of central line associated bloodstream infections is typically expressed as the number o...
What is the current status of trial NCT01165411?
This trial is currently completed. The enrollment target is 4,530 participants. The study started on 2008-08. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT01165411?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702878 · 4,514 participants · Phase 3
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia